VASCALACE CAPS 2.5 ramipril 2.5 mg capsule bottle Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

vascalace caps 2.5 ramipril 2.5 mg capsule bottle

strides pharma science pty ltd - ramipril, quantity: 2.5 mg - capsule - excipient ingredients: hydrophobic colloidal silica anhydrous; pregelatinised maize starch; titanium dioxide; purified water; iron oxide yellow; gelatin; sodium lauryl sulfate; brilliant scarlet 4r - ? treatment of hypertension. data are currently not available to support the use of ramipril in renovascular hypertension. ,? post mi heart failure ,? prevention of progressive renal failure in patients with persistent proteinuria in excess of 1 g/day. ,? for reducing the risk of myocardial infarction, stroke, cardiovascular death or the need for revascularisation procedures in patients 55 years of age or more who have clinical evidence of coronary artery disease, stroke, or peripheral vascular disease. ,? for reducing the risk of myocardial infarction, stroke, cardiovascular death or revascularisation procedures in diabetic patients 55 years or more with one or more of the following risk factors: systolic blood pressure >160mmhg or diastolic blood pressure >90mmhg (or on antihypertensive treatment); total cholesterol >5.2mmol/l; hdl cholesterol <0.9mmol/l; current smoker; known microalbuminuria; any evidence of previous vascular disease.

Iridex PASCAL Synthesis Ophthalmic Scanning Laser System Singapur - anglès - HSA (Health Sciences Authority)

iridex pascal synthesis ophthalmic scanning laser system

topcon singapore medical pte. ltd. - ophthalmology - the pascal® synthesis ophthalmic scanning laser system is intended for use in the treatment of ocular pathology in both the posterior and anterior segments. intended for use in the posterior segment to perform retinal photocoagulation, panretinal photocoagulation, focal photocoagulation and grid photocoagulation for vascular and structural abnormalities of the retina and choroid including: (532nm, and 577nm) •proliferative and non-proliferative diabetic retinopathy •macular edema •choroidal neovascularization associated with wet age-related macular degeneration •age-related macular degeneration •lattice degeneration •retinal tears and detachments intended for use in the treatment of ocular pathology in the anterior segment including: (532 nm, and 577 nm) •iridotomy •trabeculoplasty

SMT Swiss Microtechnology PASCAL DYNAMIC CONTOUR TONOMETER Singapur - anglès - HSA (Health Sciences Authority)

smt swiss microtechnology pascal dynamic contour tonometer

mandarin opto-medic co pte ltd - ophthalmology - the pascal dynamic contour tonometer is a diagnostic device that serves for measuring intra-ocular pressure (iop) according to the dynamic contour tonometry method. the device is also capable of measuring short term pressure fluctuations within the eye. pascal is especially indicated in glaucoma.

Ascoxal mouthwash Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

ascoxal mouthwash

astrazeneca limited - ascorbic acid 100mg;  ;  ;  ; copper (ii) sulfate pentahydrate 0.2mg; sodium percarbonate 90mg - soluble tablet - active: ascorbic acid 100mg       copper (ii) sulfate pentahydrate 0.2mg sodium percarbonate 90mg excipient: acacia erythrosine magnesium stearate maize starch menthol povidone purified talc saccharin sodium sodium bicarbonate tartaric acid

ALROXAL KIT KIT Índia - anglès - Central Drugs Standard Control Organization

alroxal kit kit

aldok ph. - fluconazole,azithromycin,secnidazole - kit - 150mg,1g,750mg - kit

ASCORIL-C 50/100;ML SYR Índia - anglès - Central Drugs Standard Control Organization

ascoril-c 50/100;ml syr

glenmark - codeine phos.,chlorpheniramine maleate - syr - 10,4;mg/5ml - 50/100;ml